E J Kidd - JoVE Visualize

Showing results (11-20 of 24) with videos related to

Pageof 3

Sort By:

Pharmacology|August 8, 2001

Distribution of P2X(1) and P2X(3) receptors in the rat and human urinary bladderS Elneil, J N Skepper, E J Kidd, et al.

British Journal of Pharmacology|April 26, 2000

Apparent species differences in the kinetic properties of P2X(7) receptorsA D Hibell, E J Kidd, I P Chessell, et al.

Autonomic & Autacoid Pharmacology|March 24, 2006

Radioligand binding and functional responses of ligands for human recombinant adenosine A(3) receptorsL Yates, J H Clark, T J Martin, et al.

European Journal of Pharmacology|April 27, 1988

MDL 72832: a potent and stereoselective ligand at central and peripheral 5-HT1A receptorsA K Mir, M Hibert, M D Tricklebank, et al.

Molecular Pharmacology|October 1, 1995

Localization of P2X purinoceptor transcripts in the rat nervous systemE J Kidd, C B Grahames, J Simon, et al.

British Journal of Pharmacology|January 15, 2015

LPS exacerbates functional and inflammatory responses to ovalbumin and decreases sensitivity to inhaled fluticasone propionate in a guinea pig model of asthmaA P P Lowe, R S Thomas, A T Nials, et al.

Brain Research|May 28, 1993

5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminalsE J Kidd, A M Laporte, X Langlois, et al.

British Journal of Pharmacology|May 9, 2012

Bronchoprotection in conscious guinea pigs by budesonide and the NO-donating analogue, TPI 1020, alone and combined with tiotropium or formoterolD l Turner, N Ferrari, W R Ford, et al.

Molecular Pharmacology|August 1, 1997

Localization and functional expression of splice variants of the P2X2 receptorJ Simon, E J Kidd, F M Smith, et al.

The Journal of Pharmacology and Experimental Therapeutics|February 1, 1993

New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptorsE J Kidd, S Haj-Dahmane, T Jolas, et al.

Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:

Pageof 3

Pharmacology|August 8, 2001

Distribution of P2X(1) and P2X(3) receptors in the rat and human urinary bladderS Elneil, J N Skepper, E J Kidd, et al.

British Journal of Pharmacology|April 26, 2000

Apparent species differences in the kinetic properties of P2X(7) receptorsA D Hibell, E J Kidd, I P Chessell, et al.

Autonomic & Autacoid Pharmacology|March 24, 2006

Radioligand binding and functional responses of ligands for human recombinant adenosine A(3) receptorsL Yates, J H Clark, T J Martin, et al.

European Journal of Pharmacology|April 27, 1988

MDL 72832: a potent and stereoselective ligand at central and peripheral 5-HT1A receptorsA K Mir, M Hibert, M D Tricklebank, et al.

Molecular Pharmacology|October 1, 1995

Localization of P2X purinoceptor transcripts in the rat nervous systemE J Kidd, C B Grahames, J Simon, et al.

British Journal of Pharmacology|January 15, 2015

LPS exacerbates functional and inflammatory responses to ovalbumin and decreases sensitivity to inhaled fluticasone propionate in a guinea pig model of asthmaA P P Lowe, R S Thomas, A T Nials, et al.

Brain Research|May 28, 1993

5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminalsE J Kidd, A M Laporte, X Langlois, et al.

British Journal of Pharmacology|May 9, 2012

Bronchoprotection in conscious guinea pigs by budesonide and the NO-donating analogue, TPI 1020, alone and combined with tiotropium or formoterolD l Turner, N Ferrari, W R Ford, et al.

Molecular Pharmacology|August 1, 1997

Localization and functional expression of splice variants of the P2X2 receptorJ Simon, E J Kidd, F M Smith, et al.

The Journal of Pharmacology and Experimental Therapeutics|February 1, 1993

New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptorsE J Kidd, S Haj-Dahmane, T Jolas, et al.

Pageof 3